Case report: Rare myeloid sarcoma development following renal transplantation with KRAS and DNMT3A gene mutations
Abstract Background A high incidence of malignant tumors, such as post-transplant lymphoproliferative disorders (PTLD), Kaposi sarcoma, and renal cancer is common in solid organ and bone marrow transplant recipients. However, myeloid sarcoma (MS) after renal transplantation has rarely been reported...
Saved in:
Main Authors: | Danyang Wu (Author), Xiaoxuan Lu (Author), Xiaojing Yan (Author), Ran Gao (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The myeloid sarcoma treated by Venetoclax with hypomethylating agent followed by stem cell transplantation: rare case report
by: Aleksina Shatilova, et al.
Published: (2021) -
The KRAS key to modelling childhood sarcoma
Published: (2022) -
Pediatric acute myeloid leukemia/ myeloid sarcoma: A series of cases with rare presentations
by: Malav Thakkar, et al.
Published: (2022) -
KRAS mutations and endometriosis burden of disease
by: Natasha L Orr, et al.
Published: (2023) -
Establishment and Optimization of Radiomics Algorithms for Prediction of KRAS Gene Mutation by Integration of NSCLC Gene Mutation Mutual Exclusion Information
by: Jingyi Wang, et al.
Published: (2022)